Home/Filings/4/0001384101-24-000165
4//SEC Filing

EPSTEIN ROBERT S 4

Accession 0001384101-24-000165

CIK 0001384101other

Filed

Nov 13, 7:00 PM ET

Accepted

Nov 14, 4:35 PM ET

Size

8.5 KB

Accession

0001384101-24-000165

Insider Transaction Report

Form 4
Period: 2024-11-12
Transactions
  • Sale

    Common Stock

    2024-11-12$38.32/sh15,000$574,83044,598 total
  • Exercise/Conversion

    Common Stock

    2024-11-12$8.04/sh+15,000$120,60059,598 total
  • Exercise/Conversion

    Stock Option (right to buy)

    2024-11-1215,00020,000 total
    Exercise: $8.04Exp: 2025-01-12Common Stock (15,000 underlying)
Footnotes (3)
  • [F1]The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 9, 2024.
  • [F2]Represents weighted average sales price. Sale prices for the transactions range from $38.00 to $38.73. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.
  • [F3]The option is fully vested.

Issuer

VERACYTE, INC.

CIK 0001384101

Entity typeother

Related Parties

1
  • filerCIK 0001252004

Filing Metadata

Form type
4
Filed
Nov 13, 7:00 PM ET
Accepted
Nov 14, 4:35 PM ET
Size
8.5 KB